Avience Biomedicals (NSE:AVIENCE) Inventories, Work In Process: ₹15.3 Mil (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Inventories, Work In Process?

Avience Biomedicals NSE:AVIENCE 5 Inventories, Work In Process is ₹15.3 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Avience Biomedicals's work in process for the quarter that ended in Jan. 2026 was ₹15.3 Mil.

Avience Biomedicals Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Inventories, Work In Process Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Inventories, Work In Process
0.03 0.64 10.60

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Inventories, Work In Process 0.03 0.64 10.60 15.34
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ₹15.3 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Inventories, Work In Process of ₹15.3 Mil as of Jan. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' Inventories, Work In Process too high?
Avience Biomedicals' current Inventories, Work In Process is ₹15.3 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Inventories, Work In Process compare to ABT and SYK?
Avience Biomedicals' Inventories, Work In Process of ₹15.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Medical Devices & Instruments company?
A good Inventories, Work In Process depends on the Medical Devices & Instruments industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Inventories, Work In Process is ₹15.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Inventories, Work In Process of ₹15.3 Mil. The current Inventories, Work In Process is ₹15.3 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Inventories, Work In Process is ₹15.3 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price